Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-542X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications ; volume:13 ; number:5 ; day:20 ; month:9 ; year:2011 ; pages:1-12 ; date:10.2011
Breast cancer research ; 13, Heft 5 (20.9.2011), 1-12, 10.2011

Creator: Muranen, Taru A.

Contributor: Greco, Dario
Fagerholm, Rainer
Kilpivaara, Outi
Kämpjärvi, Kati
Aittomäki, Kristiina
Blomqvist, Carl
Heikkilä, Päivi
Borg, Åke
Nevanlinna, Heli
SpringerLink (Online service)

DOI: 10.1186/bcr3015

URN: urn:nbn:de:1111-2016032412529

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Muranen, Taru A.
Greco, Dario
Fagerholm, Rainer
Kilpivaara, Outi
Kämpjärvi, Kati
Aittomäki, Kristiina
Blomqvist, Carl
Heikkilä, Päivi
Borg, Åke
Nevanlinna, Heli
SpringerLink (Online service)

Other Objects (12)

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

Comprehensive analysis of NuMAvariation in breast cancer

BACH1 Ser919Pro variant and breast cancer risk

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

Mast cells and eosinophils in invasive breast carcinoma

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

Comprehensive analysis of NuMAvariation in breast cancer

BACH1 Ser919Pro variant and breast cancer risk

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

Mast cells and eosinophils in invasive breast carcinoma

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

Comprehensive analysis of NuMAvariation in breast cancer

BACH1 Ser919Pro variant and breast cancer risk

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

Mast cells and eosinophils in invasive breast carcinoma

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

Comprehensive analysis of NuMAvariation in breast cancer

BACH1 Ser919Pro variant and breast cancer risk

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

Mast cells and eosinophils in invasive breast carcinoma

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

Comprehensive analysis of NuMAvariation in breast cancer

BACH1 Ser919Pro variant and breast cancer risk

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

Mast cells and eosinophils in invasive breast carcinoma

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

Comprehensive analysis of NuMAvariation in breast cancer

BACH1 Ser919Pro variant and breast cancer risk

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

Mast cells and eosinophils in invasive breast carcinoma

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Related objects

Reset password